SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
DEBONE LOUIS J

(Last) (First) (Middle)
781 CHESTNUT RIDGE RD
P O BOX 4310

(Street)
MORGANTOWN WV 26505

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MYLAN LABORATORIES INC [ MYL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2003
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 11/03/2003 M 26,100 A $7.4169 149,850 D
Common Stock 11/03/2003 S 26,100 D $23.8867 123,750 D
Common Stock 11/04/2003 M 41,400 A $7.4169 165,150 D
Common Stock 11/04/2003 M 67,500 A $7.8889 232,650 D
Common Stock 11/04/2003 S 108,900 D $23.8943 123,750(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option - Right to Buy $7.4169 11/03/2003 M 26,100 07/25/1997 07/25/2007 Common Stock 26,100 $7.4169 41,400 D
Employee Stock Option - Right to Buy $7.4169 11/04/2003 M 41,400 07/25/1997 07/25/2007 Common Stock 41,400 $7.4169 0 D
Employee Stock Option - Right to Buy $7.8889 11/04/2003 M 67,500 01/29/1998 01/29/2008 Common Stock 67,500 $7.8889 0 D
Explanation of Responses:
1. All information in this Form 4 reflects the three-for-two stock split effective as of October 8, 2003.
2. Includes 90,000 shares of restricted stock previously granted to the Reporting Person. Mylan Laboratories Inc. common stock indirect ownership through 401(k) holdings was 13,631 shares as of November 3, 2003.
/s/ Louis J. DeBone 11/04/2003
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.